| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |